List of sgRNA/shRNA target sequences for validation of CRISPR screen hits
| Target name . | sgRNA/shRNA target sequences . |
|---|---|
| sgGFP | GAGATCGAGTGCCGCATCAC |
| sgControl | GCCCGTTTCGTCATTCCCAC |
| sgAAVS | ATTCCCAGGGCCGGTTAATG |
| sgATXN7L3-1 | ACAGCACACAGATGAGCAG |
| sgATXN7L3-2 | TTGTTGGAACCTAGGCCGG |
| sgENY2-1 | GTGGCTGAAATCACTCCAAA |
| sgENY2-2 | ACACGTTACTGTTGATGACT |
| sgUSP22-1 | AGACATGGAAATAATCGCCA |
| sgUSP22-2 | AAGGCGAAGCGGCACAACCT |
| sgFCGR1A-1 | GACATCCCCACTCCTGGAG |
| sgFCGR1A-2 | TGGGAGCAGCTCTACACAG |
| shControl | CGAGGGCGACTTAACCTTAGG |
| shUSP22-1 | CCTACCTGCTGTAAGATTATG |
| shUSP22-2 | AGCTACCAGGAGTCCACAAAG |
| shENY2-1 | CCAGCCTTTAAGATTGAATTA |
| shENY2-2 | GCACACTGTAAAGAGGTAATT |
| shATXN7L3-1 | AGGCGAACCGTACGGATTTAT |
| shATXN7L3-2 | GCAGGCAGAGGATCCGATTAT |
| Target name . | sgRNA/shRNA target sequences . |
|---|---|
| sgGFP | GAGATCGAGTGCCGCATCAC |
| sgControl | GCCCGTTTCGTCATTCCCAC |
| sgAAVS | ATTCCCAGGGCCGGTTAATG |
| sgATXN7L3-1 | ACAGCACACAGATGAGCAG |
| sgATXN7L3-2 | TTGTTGGAACCTAGGCCGG |
| sgENY2-1 | GTGGCTGAAATCACTCCAAA |
| sgENY2-2 | ACACGTTACTGTTGATGACT |
| sgUSP22-1 | AGACATGGAAATAATCGCCA |
| sgUSP22-2 | AAGGCGAAGCGGCACAACCT |
| sgFCGR1A-1 | GACATCCCCACTCCTGGAG |
| sgFCGR1A-2 | TGGGAGCAGCTCTACACAG |
| shControl | CGAGGGCGACTTAACCTTAGG |
| shUSP22-1 | CCTACCTGCTGTAAGATTATG |
| shUSP22-2 | AGCTACCAGGAGTCCACAAAG |
| shENY2-1 | CCAGCCTTTAAGATTGAATTA |
| shENY2-2 | GCACACTGTAAAGAGGTAATT |
| shATXN7L3-1 | AGGCGAACCGTACGGATTTAT |
| shATXN7L3-2 | GCAGGCAGAGGATCCGATTAT |
Multiple targets and their respective sequences based on the results from the CRISPR screen are shown (Figures 2 and 3). sgRNAs were validated in Cas9-expressing AML2 and AML3 cell lines or AML2 and AML3 cells.
shRNA, short hairpin RNA.